Navigation Links
SAFE-BioPharma Webinar Featuring ARX's Digital Signature Solution and Adobe LiveCycle Combined Solution
Date:5/20/2009

The webinar will illustrate how ARX's CoSign® digital signatures fully integrate with Adobe LiveCycle® ES, decreasing costs while increasing efficiency and quality of regulated documentation and processes.

San Francisco, CA (PRWEB) May 20, 2009 -- On May 21st at 2pm (EST) ARX, Inc., the provider of the CoSign digital signature (standard electronic signature) solution, and Adobe, the worldwide ECM solution provider, will be addressing the benefits provided by the combined Adobe LiveCycle ES and ARX CoSign digital signature solution in a SAFE-BioPharma sponsored webinar. To register for the event, please click here.

The integrated solution, which was co-designed by Adobe and ARX to dovetail their product capabilities, offers FDA-regulated organizations a comprehensive system specifically for the life sciences market. It provides increased speed and agility, enhanced operational efficiency, and the ability to collaborate and outsource with a secure and compliant environment.

The combined solution features include PDF document management, Roaming ID, centralized digital signatures with end-user key and certificate management, end-user signing required for trusted approval and verification-dependent workflows without the need for plug-ins, as well as SAFE-compliance. The deployment results in fully-automated and secure approval processes that create digitally signed electronic records for both internal operations and applications that extend to the external collaborative ecosystem including regulatory submissions.

Solution features include PDF document management, Roaming ID, centralized digital signatures with end-user key and certificate management, end-user signing required for trusted approval and verification-dependent workflows without the need for plug-ins, as well as SAFE-compliance. The deployment results in fully-automated and secure approval processes that create digitally signed electronic records for both internal operations and applications that extend to the external collaborative ecosystem including regulatory submissions.

Via the integration with Adobe LiveCycle ES, ARX continues its commitment to delivering CoSign as a packaged, turn-key digital signature solution that is easily extensible for supporting best-in-class 3rd party applications.

"Clients have the option of using the standard Certificate Authority (CA) in CoSign, or easily integrating with an in-house CA or leading 3rd party certification authority services," said Rodd Schlerf, Life Science Market Manager at ARX. Mr. Schlerf continued, "Likewise, with Adobe LiveCycle ES and the integrated offering of Roaming ID, and PDF, PDF/A document management, we have braided together the most widely-deployed digital signature system in the FDA-regulated market (ARX CoSign), the predominant document format in the FDA-regulated market (Adobe's PDF), and automation of approval processes and security throughout the lifecycle of an electronic record (Adobe LiveCycle ES)."

CoSign fully supports SAFE-certified deployments and provides the lowest Total Cost of Ownership (TCO) for digital signature implementations with total installation time typically being 2-4 hours. CoSign manages this while supporting best-in-class complimentary technologies that meet the business needs of any organization.

To register for the event, please click here.

About CoSign Digital Signatures
CoSign makes it easy to digitally sign transactions, documents, and records by embedding the standard signature technology directly into mainstream business applications. CoSign produces a signature record for every signature it captures. This Portable Signature Format (CoSign PSF™) allows anyone to seamlessly verify and retain proof of identity, intent, and document integrity without costly, complicated, or proprietary software. CoSign keeps your business running smoothly by fully automating and quickly scaling processes at a low cost and with proper controls. Learn more at www.arx.com/products/cosign_moreinfo.php.

About The Digital Signature Company - ARX
ARX (Algorithmic Research) is a global provider of cost-efficient digital signature solutions for industries such as life sciences, healthcare, government, and engineering. ARX engineers and scientists have more than 20 years of experience in security and standard digital signature application. ARX helps businesses secure, streamline, and scale their business processes and transactions with the proper controls required by legislation, regulation, and industry best practice. Visit us at www.arx.com.

CoSign is a registered trademark and CoSign PSF is a trademark of Algorithmic Research, Ltd. All other trade names and trademarks are the property of their respective holders.

###

Read the full story at http://www.prweb.com/releases/Digital-Signatures/CoSign/prweb2438914.htm.


'/>"/>
Source: PRWeb
Copyright©2009 Vocus, Inc.
All rights reserved  

Related medicine news :

1. Aladdin eToken First Strong Authentication Device to Achieve Certification from the SAFE-BioPharma Association
2. Uncover Key Competitive Intelligence Insights in Webinars Hosted by Best Practices
3. Portico Systems Offers Webinar Series to Share Provider Network Management Best Practices
4. FairWarning to Host Webinar Featuring HIMSS Chairman and Healthcare Executive from PricewaterhouseCoopers on Electronic Health Record Privacy and Compliance Challenges
5. Pharsight to Host Webinar on Hepatitis C Virus (HCV) and HIV Drug-Disease Modeling
6. Achieving CVIS Goals Webinar
7. Agilysys Hosts IBM Specialist at Health Care Webinar Offering Data Storage Solutions
8. Plexus Systems, Inc. and Aberdeen Group Co-host March 27 Webinar on Manufacturing Efficiency
9. Recognized Authority on Boomers Over 50 to Present an Environments for Aging Webinar
10. Leveraging CVIS Integration to Automate Anticoagulation Therapy Webinar
11. Milliman Announces Encore Webinar on Practical Uses of Lifestyle-Based Analytics (LBA) in Risk Selection
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
SAFE-BioPharma Webinar Featuring ARX's Digital Signature Solution and Adobe LiveCycle Combined Solution
(Date:2/10/2016)... ... February 10, 2016 , ... ... digital self-scheduling readily available to physicians. The integration will enable Allscripts users ... select appointments via Everseat’s free mobile app. , The partnership gives Everseat substantial ...
(Date:2/10/2016)... ... February 10, 2016 , ... ... 32224, February 26th: Amateur & Professional Divisions - Time: 7:00pm – 10:00pm ... 10:00pm | Ticket Prices $30, Social Media: http://www.USPoleSportsFed.org , Facebook: ...
(Date:2/10/2016)... ... 10, 2016 , ... Workrite Ergonomics, who is celebrating their 25th year of ... to being an internationally recognized leader in their industry. , "We are very proud ... President of Workrite. “Workrite recognized the importance of good ergonomics before most of ...
(Date:2/10/2016)... ... ... Anxiety of older Americans over steep cost increases of prescription drugs is at ... to The Senior Citizens League (TSCL). Since last fall, TSCL has ... costs. “The implications are chilling, particularly for people with chronic health problems,” says ...
(Date:2/10/2016)... , ... February 09, 2016 , ... ... and staff helped give free oral screenings to 150 children in kindergarten through ... , The College of Dental Medicine joined Chinese American Dental Society of Southern ...
Breaking Medicine News(10 mins):
(Date:2/10/2016)... LONDON , February 10, 2016 A new report ... 2021 - states that the Alzheimer,s disease market will more than double ... 2021, at a Compound Annual Growth Rate (CAGR) of 11%. ... Italy , Spain , the UK, and ... prevalence during the forecast period. --> Canada , ...
(Date:2/10/2016)... SAN DIEGO , Feb. 10, 2016 ... viral gene therapy manufacturing, and Renova™ Therapeutics, a biopharmaceutical ... and other chronic diseases, have entered into a Manufacturing ... produce cGMP-grade RT-100 (Ad5.hAC6) Drug Product for use in ... --> This relationship will leverage Lonza,s ...
(Date:2/10/2016)... , Feb. 10, 2016 Immune Pharmaceuticals Inc. ... announced today that it has filed a patent application ... other cancers. --> --> ... by administration of Ceplene (histamine dihydrochloride) in combination with ... of predicting the efficacy of Ceplene and IL-2 therapy ...
Breaking Medicine Technology: